France
· Delayed Price · Currency is EUR Ramsay Générale de Santé Statistics
Total Valuation
Ramsay Générale de Santé has a market cap or net worth of EUR 1.74 billion. The enterprise value is 5.45 billion.
| Market Cap | 1.74B |
| Enterprise Value | 5.45B |
Important Dates
The next estimated earnings date is Thursday, September 5, 2024.
| Earnings Date | Sep 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ramsay Générale de Santé has 110.37 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Shares Outstanding | 110.37M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +39.31% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 0.01% |
| Float | 863,776 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 1.52 |
| P/FCF Ratio | 4.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 13.03.
| EV / Earnings | -101.12 |
| EV / Sales | 1.09 |
| EV / EBITDA | 9.64 |
| EV / EBIT | 39.38 |
| EV / FCF | 13.03 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 327.73.
| Current Ratio | 0.87 |
| Quick Ratio | 0.62 |
| Debt / Equity | 327.73 |
| Debt / EBITDA | 7.13 |
| Debt / FCF | 9.63 |
| Interest Coverage | 0.70 |
Financial Efficiency
Return on equity (ROE) is -2.93% and return on invested capital (ROIC) is 1.63%.
| Return on Equity (ROE) | -2.93% |
| Return on Assets (ROA) | 1.25% |
| Return on Capital (ROIC) | 1.63% |
| Revenue Per Employee | 131,750 |
| Profits Per Employee | -1,418 |
| Employee Count | 38,000 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 29.89 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.30% in the last 52 weeks. The beta is 0.17, so Ramsay Générale de Santé's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -23.30% |
| 50-Day Moving Average | 15.50 |
| 200-Day Moving Average | 16.30 |
| Relative Strength Index (RSI) | 60.12 |
| Average Volume (20 Days) | 208 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ramsay Générale de Santé had revenue of EUR 5.01 billion and -53.90 million in losses. Loss per share was -0.49.
| Revenue | 5.01B |
| Gross Profit | 1.37B |
| Operating Income | 138.40M |
| Pretax Income | -40.80M |
| Net Income | -53.90M |
| EBITDA | 565.10M |
| EBIT | 138.40M |
| Loss Per Share | -0.49 |
Balance Sheet
The company has 359.00 million in cash and 4.03 billion in debt, giving a net cash position of -3.67 billion or -33.26 per share.
| Cash & Cash Equivalents | 359.00M |
| Total Debt | 4.03B |
| Net Cash | -3.67B |
| Net Cash Per Share | -33.26 |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 10.41 |
| Working Capital | -216.90M |
Cash Flow
In the last 12 months, operating cash flow was 586.80 million and capital expenditures -168.50 million, giving a free cash flow of 418.30 million.
| Operating Cash Flow | 586.80M |
| Capital Expenditures | -168.50M |
| Free Cash Flow | 418.30M |
| FCF Per Share | 3.79 |
Margins
Gross margin is 27.40%, with operating and profit margins of 2.76% and -1.08%.
| Gross Margin | 27.40% |
| Operating Margin | 2.76% |
| Pretax Margin | -0.81% |
| Profit Margin | -1.08% |
| EBITDA Margin | 11.29% |
| EBIT Margin | 2.76% |
| FCF Margin | 8.36% |
Dividends & Yields
Ramsay Générale de Santé does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -3.10% |
| FCF Yield | 23.99% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |